Paper42908005PubMed
Sphingolipid metabolic subtyping defines SPHK1 as an oncogene and characterizes immunosuppressive TME features in gastric cancer.
Wang Z and 2 others. Cancer Cell Int, 2026.
Cite this record
ConductScience Library. Sphingolipid metabolic subtyping defines SPHK1 as an oncogene and characterizes immunosuppressive TME features in gastric cancer. Papers, record 42908005. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42908005
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Sphingolipid metabolic subtyping defines SPHK1 as an oncogene and characterizes immunosuppressive TME features in gastric cancer.
- Journal
- Cancer Cell Int
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-10-24
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| JZXKCTS-2024-06 | Jiading District Central Hospital Scientific Research Innovation Exploration Program | PubMed | ||
| JDKW-2025-0028 | Jiading District Natural Science Research Project | PubMed |
Source PubMed
References79
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26662312 | SphK1 promotes tumor cell migration and invasion in colorectal cancer. | Tumour Biol | 2016 | https://conductscience.org/library/papers/26662312 | PubMed |
| 2 | 32402091 | Role of sphingolipid metabolism in neurodegeneration. | J Neurochem | 2021 | https://conductscience.org/library/papers/32402091 | PubMed |
| 3 | 37507302 | Sphingolipid metabolism and complement signaling in cancer progression. | Trends Cancer | 2023 | https://conductscience.org/library/papers/37507302 | PubMed |
| 4 | 40394027 | Sphingolipid metabolism-related genes as diagnostic markers in pneumonia-induced sepsis: the AUG model. | Sci Rep | 2025 | https://conductscience.org/library/papers/40394027 | PubMed |
| 5 | 39671294 | Metabolic reprogramming, sensing, and cancer therapy. | Cell Rep | 2024 | https://conductscience.org/library/papers/39671294 | PubMed |
| 6 | 29654831 | Fingolimod interrupts the cross talk between estrogen metabolism and sphingolipid metabolism within prostate cancer cells. | Toxicol Lett | 2018 | https://conductscience.org/library/papers/29654831 | PubMed |
| 7 | 25382749 | Sphingolipid metabolism and interorganellar transport: localization of sphingolipid enzymes and lipid transfer proteins. | Traffic | 2015 | https://conductscience.org/library/papers/25382749 | PubMed |
| 8 | 38077400 | Single-cell sequencing analysis related to sphingolipid metabolism guides immunotherapy and prognosis of skin cutaneous melanoma. | Front Immunol | 2023 | https://conductscience.org/library/papers/38077400 | PubMed |
| 9 | 37598157 | The global prevalence of gastric cancer in Helicobacter pylori-infected individuals: a systematic review and meta-analysis. | BMC Infect Dis | 2023 | https://conductscience.org/library/papers/37598157 | PubMed |
| 10 | 40537868 | Sphingolipid metabolism-related genes for the diagnosis of metabolic syndrome by integrated bioinformatics analysis and Mendelian randomization identification. | Diabetol Metab Syndr | 2025 | https://conductscience.org/library/papers/40537868 | PubMed |
| 11 | 35745168 | The Role of Obesity, Inflammation and Sphingolipids in the Development of an Abdominal Aortic Aneurysm. | Nutrients | 2022 | https://conductscience.org/library/papers/35745168 | PubMed |
| 12 | 35846357 | Development of a Novel Sphingolipid Signaling Pathway-Related Risk Assessment Model to Predict Prognosis in Kidney Renal Clear Cell Carcinoma. | Front Cell Dev Biol | 2022 | https://conductscience.org/library/papers/35846357 | PubMed |
| 13 | 34268882 | SphK1-driven autophagy potentiates focal adhesion paxillin-mediated metastasis in colorectal cancer. | Cancer Med | 2021 | https://conductscience.org/library/papers/34268882 | PubMed |
| 14 | 28405684 | SphK1 modulates cell migration and EMT-related marker expression by regulating the expression of p-FAK in colorectal cancer cells. | Int J Mol Med | 2017 | https://conductscience.org/library/papers/28405684 | PubMed |
| 15 | 20334489 | Targeting sphingolipid metabolism in head and neck cancer: rational therapeutic potentials. | Expert Opin Ther Targets | 2010 | https://conductscience.org/library/papers/20334489 | PubMed |
| 16 | 40434736 | Potential of SPHK1 as a prognostic marker and therapeutic target in colorectal cancer: insights from bioinformatics and experimental analysis. | Int J Surg | 2025 | https://conductscience.org/library/papers/40434736 | PubMed |
| 17 | 27811358 | Sphk1 promotes breast epithelial cell proliferation via NF-κB-p65-mediated cyclin D1 expression. | Oncotarget | 2016 | https://conductscience.org/library/papers/27811358 | PubMed |
| 18 | 39578076 | SPHK1/S1PR1/PPAR-α axis restores TJs between uroepithelium providing new ideas for IC/BPS treatment. | Life Sci Alliance | 2025 | https://conductscience.org/library/papers/39578076 | PubMed |
| 19 | 40665874 | Targeting SPHK1 in macrophages remodels the tumor microenvironment and enhances anti-PD-1 immunotherapy efficacy in colorectal cancer liver metastasis. | Cancer Commun (Lond) | 2025 | https://conductscience.org/library/papers/40665874 | PubMed |
| 20 | 33506044 | Increased SPHK1 and HAS2 Expressions Correlate to Poor Prognosis in Pancreatic Cancer. | Biomed Res Int | 2021 | https://conductscience.org/library/papers/33506044 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42908005
GET https://conductscience.org/api/papers/v1/42908005/references?page=2